Biomarin Pharmaceutical Inc (NASDAQ:BMRN) showed up in the 13F filings of 523 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 19,135,108 | -2,910,942 | -13.20% | $1,137,199,439.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 18,127,847 | -454,738 | -2.45% | $1,077,337,946.00 |
| DODGE & COX | 31 Dec, 2025 | 14,572,384 | -114,417 | -0.78% | $866,036,781.00 |
| PRIMECAP MANAGEMENT CO/CA/ | 31 Dec, 2025 | 14,549,314 | -679,973 | -4.46% | $864,665,732.00 |
| NORGES BANK | 31 Dec, 2025 | 7,531,080 | 7,531,080 | 0.00% | $447,572,084.00 |
| State Street Corp | 31 Dec, 2025 | 7,523,218 | -1,241,381 | -14.16% | $447,104,846.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 6,686,916 | 754,807 | 12.72% | $395,196,725.00 |
| VIKING GLOBAL INVESTORS LP | 31 Dec, 2025 | 6,036,936 | -2,285,243 | -27.46% | $358,775,106.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 3,674,089 | 131,969 | 3.73% | $218,394,606.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 3,321,754 | 1,076,568 | 47.95% | $197,404,798.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 3,037,616 | 410,406 | 15.62% | $180,525,519.00 |
| Vestal Point Capital, LP | 31 Dec, 2025 | 3,000,000 | 2,170,000 | 261.45% | $178,290,000.00 |
| Capital Research Global Investors | 31 Dec, 2025 | 2,547,287 | 9,691 | 0.38% | $151,385,266.00 |
| Morgan Stanley | 31 Dec, 2025 | 2,315,620 | 935,176 | 67.74% | $137,617,375.00 |
| Deep Track Capital, LP | 31 Dec, 2025 | 2,300,000 | 2,275,144 | 9,153.30% | $136,689,000.00 |
| UBS Group AG | 31 Dec, 2025 | 2,211,721 | 671,551 | 43.60% | $131,442,578.00 |
| FMR LLC | 31 Dec, 2025 | 1,837,071 | 1,444,256 | 367.67% | $109,177,147.00 |
| Squarepoint Ops LLC | 31 Dec, 2025 | 1,828,344 | 439,820 | 31.68% | $108,658,484.00 |
| Swedbank AB | 31 Dec, 2025 | 1,593,474 | 1,126,531 | 241.26% | $94,700,160.00 |
| Northern Trust Corp | 31 Dec, 2025 | 1,547,965 | -114,303 | -6.88% | $91,995,561.00 |